SureTrader
Home > Boards > US Listed > Biotechs > Viking Therapeutics, Inc. (VKTX)

Equally excited, VK5211 est. 300,000 patients per year

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
greens12 Member Profile
 
Followed By 200
Posts 17,866
Boards Moderated 3
Alias Born 01/12/12
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2018 4:42:34 PM
Viking Therapeutics to Present at 2018 BIO CEO & Investor Conference PR Newswire (US) - 2/7/2018 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2018 4:17:13 PM
Viking Therapeutics Announces Closing of Public Offering of Common Stock PR Newswire (US) - 2/6/2018 4:05:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/5/2018 4:15:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/2/2018 9:31:36 AM
Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock PR Newswire (US) - 2/2/2018 8:33:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/1/2018 4:19:57 PM
Viking Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire (US) - 2/1/2018 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 5:52:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 5:51:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2018 5:48:12 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/17/2018 6:02:16 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/16/2018 5:19:34 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/9/2018 5:30:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/4/2018 4:16:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 4:20:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 4:20:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 4:19:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 4:19:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2018 4:18:12 PM
Viking Therapeutics to Present at Biotech Showcase 2018 PR Newswire (US) - 1/2/2018 7:05:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 12/20/2017 5:22:34 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/19/2017 2:24:35 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/18/2017 9:57:21 AM
greens12   Tuesday, 10/03/17 10:13:37 PM
Re: zoomlik post# 695
Post # of 1263 
Equally excited, VK5211 est. 300,000 patients per year in U.S and growing.. Market opp exceeds 1 billion annually, Potential benefits in other fractures besides just the Hip.
There are no other approved therapy's so VKTX would be the only player with a drug for this indication.

VKTX


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist